Scientists Rejuvenate Skin Cells by 30 Years, with Pioneering Potential
As previously reported by BioSpace, a group of scientists from the Babraham Institute in the United Kingdom was able to successfully rejuvenate skin cells by a full 30 years.
New Search
If you are not happy with the results below please do another search
Search
50 search results for:
Biden may need to ‘claw back’ funding for COVID, Jha says
/in Congress, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Funding, COVID-19 Vaccines, Joe Biden, United States, White HouseThe White House is preparing for a scenario in which Congress fails to approve President Joe Biden’s request for additional COVID funds by reviewing old contracts to see if there is any money it can “claw back,” the president’s top COVID adviser said on May 12.
Massachusetts to pay $56 million over deadly COVID outbreak at veterans’ home
/in Coronavirus, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Deaths, Legal, Massachusetts, Nursing, Outbreaks, Settlements, VeteransThe state of Massachusetts on May 12 agreed to pay $56 million to resolve a lawsuit by families of veterans who contracted COVID-19 during an outbreak at a veterans’ care center that killed 84 people early in the pandemic.
The Risks and Rewards of Decentralized Clinical Trials
/in Business, Clinical Trials, Coronavirus Disease 2019 (COVID-19), Data quality, Decentralized Clinical Trials, Mobile, Patient safety, R&D, Researchers, Technology, TelemedicineFor years, researchers have been moving towards decentralized clinical trials (DCTs), and in a matter of months, COVID-19 changed the trajectory. Clinical operations teams and investigator sites around the world rose to the challenge and worked quickly to deploy new tactics to serve their study participants. The resulting reward is that DCTs, which can be leveraged smartly to reduce participant burden and improve recruitment and retention, are now becoming more widely adopted in design considerations. But rewards bring about new risks and challenges, and DCTs create new concerns for monitoring participant safety. Dario Lirio – Senior Director, LifeSphere Clinical at ArisGlobal – analyzes the risks and rewards of DCTs.
Symptoms linger two years for some; inflammatory protein patterns may provide long COVID clues
/in Blood, China, COVID-19 Studies, COVID-19 Vaccines, Hospitalized COVID-19 Patients, Long COVID, Omicron BA.2, R&D, Symptoms: Coronavirus Disease 2019 (COVID-19), The Lancet Respiratory DiseasesHalf of the COVID-19 patients discharged from a Chinese hospital in early 2020 still have at least one symptom two years later, a new study shows. Additionally, new findings suggest patterns of inflammatory proteins in the blood of people with long COVID may someday help guide individualized treatment.
Old Needs, New Technology: Imagining a More Connected Future
/in Apple Watch, Consumer Brands, Consumers, Digital, Digital therapeutics, Health Technology, Healthcare, Healthcare Communications Agencies, Marketing & Advertising, Medical Devices, Mental Health, Metaverse, Telehealth, Therapeutics, Virtual Reality, WearablesIf you flip through history, you’ll realize that our fundamental healthcare needs haven’t changed since the year 1885. We still seek rest when we’re ill, feel pain when we overexert ourselves, and need guidance from experts on our health and wellness. But the tools we have to meet these perennial needs have shifted dramatically since the 19th century, and especially over the past decade, wherein technology has advanced faster than even the greatest Sci-Fi film producers imagined, according to Greater Than One Chief Technology Officer Ken Winell.
Introducing Klick Health ‘Maker’ Bernardo Romero
/in Agency Launches, Appointments, Diabetes, Expansion, Healthcare Communications Agencies, Healthcare Marketers, Marketing, Marketing & Advertising, Medicine Avenue, New Hire, New Hires, New Offerings, People on the Move, Q&AKlick Health hired 37-time Cannes Lions and 80-time Clio awards recipient Bernardo Romero to become the agency’s ‘Maker’ – a role that was specially created around his desire to return to creating campaigns and products that positively impact people’s health. Romero, who was Chief Creative Officer at The Bloc, wants to bring his patient experience as someone who has diabetes into his work. Romero and Klick Health Chief Creative Officer Rich Levy talked to Med Ad News about what brought Romero to Klick and the launch of The Workshop, a Klick team of “Makers, Concepters, Noodlers and Doodlers” that will be experimenting with new ideas for creative healthcare advertising.
Cullinan Oncology and Taiho reunite to co-develop NSCLC drug
/in Acquisitions, Biopharma Companies, Business, Collaborations, EGFR exon 20 insertion mutations, EGFR tyrosine kinase inhibitors (TKI), Licensing, Non-Small Cell Lung Cancer, R&D, R&D, Taiho PharmaceuticalCullinan Oncology and Taiho Pharmaceutical announced that Taiho was acquiring Cullinan Pearl and will co-develop and co-commercialize a non-small cell lung cancer (NSCLC) drug.
BMS & BridgeBio team up in nearly $1B oncology pact
/in Biopharma Companies, BioSpace, Bristol Myers Squibb, Business, Cancer, Collaborations, Commercialization, Deals, Licensing, MD Anderson Cancer Center, Oncology, R&D, R&D, SHP2 inhibitors, TumorsBridgeBio announced that the Palo Alto, Calif.-based biopharmaceutical company signed an exclusive deal with Bristol Myers Squibb to develop and commercialize a potential treatment for cancer.
U.S. will share COVID-19 vaccine technology, Biden tells global summit
/in Antivirals, BNT162b2 (Pfizer and BioNTech), Congress, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, COVID-19 Therapeutic, COVID-19 therapeutic candidates, COVID-19 Therapeutics, COVID-19 Therapies, COVID-19 Vaccines, Janssen COVID-19 Vaccine (J&J), Joe Biden, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Pandemic Preparedness, Pandemics, Summits, Therapeutics, U.S. government, United States, Vaxzevria (previously COVID-19 Vaccine AstraZeneca), WHO, World Bank, World Health OrganizationThe United States will share technologies used to make COVID-19 vaccines through the World Health Organization and is working to expand rapid testing and antiviral treatments for hard-to-reach populations, President Joe Biden said on May 12.